Case 4: Antiretroviral Therapy for Acute (Primary) HIV- Antiretroviral Rx

Case-Based Modules
Initial Evaluation
Dermatologic Manifestations
Oral Manifestations
OIs: Prophylaxis
OIs: Treatment
Antiretroviral Rx
Antiretroviral Rx: Resistance
Antiretroviral Rx: Adverse Effects
Drug-Drug Interactions
Postexposure Prophylaxis
Perinatal Transmission
Special Populations
Prevention for Positives
Challenging Unknowns
Interactive Tutorials
This program is funded through Health Resources and Services Administration, US Department of Health and Human Services.

Home
About This Site
Free CME
AETC NRC
Resources
Feedback
Site Map
Authors

Question | Discussion | References | CME Credit

Case 4: Antiretroviral Therapy for Acute (Primary) HIV

You answered:

	Transmission of antiretroviral-resistant HIV has been documented through sexual, parenteral, and vertical routes. Persons who acquire antiretroviral resistant HIV are more likely to have failures with antiretroviral therapy.

This answer is correct. Transmission of resistant HIV has clearly been documented with multiple different routes of exposure. Recent studies have shown that persons who acquire resistant HIV are more likely to fail antiretroviral therapy, with a longer time to viral suppression and a shorter time to virologic failure.

[Back to Case 4 Question | Proceed to Case 4 Discussion]